HLA-Haploidentical Hematopoietic Stem Cells Transplantation with Regulatory and Conventional T Cell Adoptive Immunotherapy in Pediatric Patients with Very High-Risk Acute Leukemia

Researchers presented outcomes of a novel HLA-haploidentical hematopoietic stem cell transplantation strategy with adoptive immunotherapy with thymic-derived CD4+CD25+ FoxP3+ regulatory T cells and conventional T cells performed in 20 children with high-risk leukemia.